Beginning with the pioneering experimental liver transplants by Vittorio Staudacher1 and eventually the successful human liver transplant by Thomas Starzl,2 the remarkable advances in liver transplant have made it a highly durable, live-saving, and quality of life–restoring operation. This success has created a tremendous demand for organs to save the lives of thousands of patients annually. A record 8896 liver transplants were performed in the United States in 2019, an increase driven largely by more aggressive use of marginal organs. Of these transplants, 22% of the recipients were older than 65 years, a 100% increase from just 10 years ago, making it the largest increase of any age group.3 This aggressive use of donor organs coupled with a higher-acuity recipient population presents a constant challenge in managing outcomes, reducing futility, and replacing a failing graft in a timely manner to avoid further recipient compromise. To that end, numerous studies have strived to identify predictors of early graft dysfunction and ultimately failure.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Busuttil RW. Predicting Early Hepatic Graft Failure—The Quest Continues. JAMA Surg. 2020;155(12):e204593. doi:10.1001/jamasurg.2020.4593
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.